Terminology Service for NFDI4Health
All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Oropharyngeal (p16-Negative) Cancer Pathologic Distant Metastasis TNM Finding v8 | NCIT_C132981 | [A pathologic finding about one or more characteristics of oropharyngeal (p16-negative) cancer, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases.] |
| Hypopharyngeal Cancer pM1 TNM Finding v8 | NCIT_C132988 | [Hypopharyngeal cancer with distant metastasis. (from AJCC 8th Ed.)] |
| Hypopharyngeal Cancer Pathologic Distant Metastasis TNM Finding v8 | NCIT_C132982 | [A pathologic finding about one or more characteristics of hypopharyngeal cancer, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases.] |
| Anti-Glypican 3-scFvGC33-CAR-expressing T Lymphocytes | NCIT_C132989 | [A preparation of autologous T-lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) containing a single chain variable fragment (scFv) derived from the anti-glypican-3 (GPC3) monoclonal antibody GC33 (scFvGC33), with potential immunostimulating and antineoplastic activities. Upon administration, anti-GPC3-scFvGC33-CAR autologous T-lymphocytes specifically target and bind to GPC3-expressing tumor cells, resulting in tumor cell lysis. GPC3, a heparan sulfate proteoglycan and a member of the glypican family, is overexpressed on certain tumor cell types while minimally expressed in normal, healthy cells.. GPC3 plays an important role in cellular proliferation and differentiation.] |
| Breast Cancer Risk Factor | NCIT_C20116 | [Any factor, such as age, ethnicity, genetic factor, family history, over-exposure to estrogen, or environmental factors, that increases a person's chance of developing breast cancer.] |
| Diffusion MRI | NCIT_C20117 | [MRI method that measure the diffusion of water in the tissue, rather than the content of water as measured in conventional MRI.] |
| International Prognostic Index | NCIT_C20118 | [A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy. The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org))] |
| PSA Velocity | NCIT_C20119 | [A type of PSA assay which compares changes in PSA levels over time. A sharp rise in the PSA level raises the suspicion of cancer. (from Cancer Information Service)] |
| United States Minor Outlying Islands | NCIT_C20112 | [The U.S. Minor Outlying Islands consist of Baker Island, Howland Island, Jarvis Island, Johnston Atoll, Kingman Reef, Midway Island, Navassa Island, Palmyra Atoll, and Wake Island (Wake Atoll).] |
| Western Sahara | NCIT_C20113 | [A country in northern Africa, bordering the North Atlantic Ocean, between Mauritania and Morocco.] |
| Binet Staging System | NCIT_C20114 | [A staging system for Chronic Lymphocytic Leukemia; it is based upon the presence or absence of anemia and/or thrombocytopenia, and involvement of lymphoid tissues, including splenic lymphoid tissue.] |
| Rai Staging System | NCIT_C20115 | [A staging system for Chronic Lymphocytic Leukemia. Stage 0: absolute lymphocytosis (>15,000 per cubic millimeter) without adenopathy, hepatosplenomegaly, anemia, or thrombocytopenia; Stage I: absolute lymphocytosis with lymphadenopathy without hepatosplenomegaly, anemia, or thrombocytopenia; Stage II: absolute lymphocytosis with either hepatomegaly or splenomegaly, with or without lymphadenopathy; Stage III: absolute lymphocytosis and anemia (hemoglobin <11 g/dL) with or without lymphadenopathy, hepatomegaly, or splenomegaly; Stage IV: absolute lymphocytosis and thrombocytopenia (<100,000 per cubic millimeter) with or without lymphadenopathy, hepatomegaly, splenomegaly, or anemia. (from OncoLink)] |
| Age-Adjusted PSA | NCIT_C20120 | [Prostate-specific antigen (PSA) level defined according to specific age groups or ranges, which takes into account the natural increase of PSA levels with increased age.] |
| Molecular Carcinogenesis | NCIT_C20121 | [Research that focuses on the genetics and mechanisms of cell transformation; the role of oxygen radicals in the carcinogenesis process; and identification and properties of tumor promoters and mechanisms of tumor promotion.] |
| Carcinogenesis Mechanism | NCIT_C18681 | [Research concerned with the metabolism, toxicity, physiological disposition, and mechanisms of action of carcinogens and their metabolites.] |
| Experimental Tobacco Carcinogenesis | NCIT_C20122 | [Studies on the toxicology and pharmacology of smoking and tobacco-related exposures. The research in this category is directed toward understanding the nature of the chemicals involved, and the reaction mechanisms behind, the deleterious effects of tobacco smoke and smokeless tobacco products.] |
| Lacrimal Duct Obstruction | NCIT_C34757 | [Blockage of the tear duct.] |
| Obstruction | NCIT_C3284 | [Blockage of the normal flow of the contents of an anatomical passageway.] |
| Visceral Larva Migrans | NCIT_C34758 | [A parasitic infection caused by worms found in domestic animals. In humans nematode larvae enter the portal system from the small intestine and disseminate in visceral organs causing inflammatory reactions. Signs and symptoms include eosinophilia, hepatomegaly, splenomegaly, and lung infections.] |
| Knee Injury | NCIT_C34753 | [Trauma to the knee.] |